Case File
efta-efta01135798DOJ Data Set 9OtherFrom: Eileen Alexanderson
Date
Unknown
Source
DOJ Data Set 9
Reference
efta-efta01135798
Pages
1
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From: Eileen Alexanderson
To: 'Jeffrey Epstein' <[email protected]>
Subject: FW: Section 734
Date: Mon, 13 May 2013 19:02:02 +0000
Attachments:
From: Fenn, Patrick [mailto:
Sent: Saturday, April 06, 2013 4:29 PM
To: Eileen Alexanderson;
Subject: FW: Section 734
; 'Thomas Turrin'
Hi. The attachment shows that, even under the most favorable conditions in the deferral context (20 year deferral of tax
on Tufts gain but full TRA benefits beginning in 21st year at a 7.5% discount rate), the value of TRA benefit is $16.5 million
for Leon. Other than by altering the discount rate and the tax rates, I don't think the TRA benefit in the deferral
(guarantee) scenario will get much better. I will leave to you to determine whether that might be enough to overcome
the non-tax aspects of the guarantee. Let me know if you want to discuss.
IRS Circular 230 Notice Requirement: This communication is not given in the form of a covered
opinion, within the meaning of Circular 230 issued by the United States Secretary of the Treasury.
Thus, we are required to inform you that you cannot rely upon any tax advice contained in this
communication for the purpose of avoiding United States federal tax penalties. In addition, any tax
advice contained in this communication may not be used to promote, market or recommend a transaction
to another party.
The information contained in this e-mail message is intended only for the personal and confidential
use of the recipient(s) named above. If you have received this communication in error, please notify
us immediately by e-mail, and delete the original message.
This email and any files transmitted with it are confidential
and intended solely for the person or entity to whom they are
addressed and may contain confidential and/or privileged
material. Any review, retransmission, dissemination or
other use of, or taking of any action in reliance upon this
information by persons or entities other than the intended
recipient is prohibited. If you have received this email in
error please contact the sender and delete the material from
any computer.
Apollo Global Management, LLC
EFTA01135798
Technical Artifacts (1)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Email
[email protected]Related Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
OtherUnknown
FEDWIRE PAYMENT DEBIT ADVICE
DOJ EFTA Data Set 10 document EFTA01273102
16p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.